Log inSign up
Moderna profile banner
user avatar

Moderna

@moderna_tx
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Cambridge, MA
modernatx.com
Joined December 2013
543
Following
145.2K
Followers
RepliesMedia
  • user avatar
    Moderna
    @moderna_tx
    Aug 19
    Along with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage
    Image
  • user avatar
    Moderna
    @moderna_tx
    Aug 19
    Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination
    Image
  • user avatar
    Moderna
    @moderna_tx
    Aug 6
    Today we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older. This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological
    Image
  • user avatar
    Moderna
    @moderna_tx
    Aug 4
    Today we announced that following Health Canada’s authorization of the study, the first participants have been vaccinated in a Phase 1 clinical study in Canada evaluating mRNA-1469, our investigational mRNA vaccine being evaluated to prevent Bundibugyo ebolavirus disease. Read
    Image